Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte Advanced VAX-31 High Dose ...
WuXi Biologics (Cayman) reported a record haul of trophies at the 2026 Asia Pacific Biopharma Excellence Awards, covering biologics development, manufacturing, and digital capabilities. The company ...
(9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has received Investigational New Drug (IND) clearance from the ...
Q: This might be a long shot, but I was diagnosed with triple negative breast cancer, had a lumpectomy with clear margins and had a recurrence six months later. I am struggling with the treatment ...
Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and improving therapeutic outcomes.
The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong ...
Today, Zacks Equity Research discusses Terns Pharmaceuticals TERN, ADMA Biologics ADMA, ANI Pharmaceuticals ANIP and Liqu ...
T Cells Gain Phagocytic Function via Specific Antigen RecognitionThe research team engineered CD8+ Jurkat T cells to express SVAR16 ...
Columbia Emerging Markets Fund returned 3.47% in Q4 2025, trailing its benchmark. Read the full analysis for more details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results